Investor updates Suchbegriff Suchen Löschen 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 Published on: 21 Januar 2020 European Commission approves Roche’s Polivy for people with previously treated aggressive lymphoma mehr Published on: 17 Januar 2020 Invitation to Roche’s live audio webcast on efficacy and safety of risdiplam in patients with type 2/3 spinal muscular atrophy presented at SMA Europe 2020 mehr Published on: 13 Januar 2020 Roche and Illumina partner to broaden patient access to genomic testing mehr Published on: 10 Januar 2020 Reminder: Invitation to Roche’s Full Year Results 2019 Presentation mehr Published on: 2 Januar 2020 F1CDx approved in Japan as a CDx of ROS1+NSCLC for Rozlytrek mehr
Published on: 21 Januar 2020 European Commission approves Roche’s Polivy for people with previously treated aggressive lymphoma mehr
Published on: 17 Januar 2020 Invitation to Roche’s live audio webcast on efficacy and safety of risdiplam in patients with type 2/3 spinal muscular atrophy presented at SMA Europe 2020 mehr
Published on: 13 Januar 2020 Roche and Illumina partner to broaden patient access to genomic testing mehr
Published on: 10 Januar 2020 Reminder: Invitation to Roche’s Full Year Results 2019 Presentation mehr